Research effort at the Aerosol Lab is dedicated to producing policy-relevant science, and to developing devices and methods needed to support its conduct. We follow contemporary problems across disciplinary boundaries. We study inhaled particle pollutants, including primary and secondary organic aerosols, and human exposure in urban settings. The lab is most known for its empirical studies of narghile waterpipe tobacco smoke and its human health effects, work in which we collaborate closely with behavioral scientists, chemists, biologists, and public health researchers to comprehensively address this fast-spreading form of tobacco use (collaborators). Some of our ongoing projects include:
- Narghile waterpipe tobacco smoke: toxicant dose, delivery, and effects
- Volatility and evaporation kinetics of atmospheric aerosols
Conceptual framework for research at the A-Lab. We address various phases in the life of particle pollutants, from physical and chemical characterization at the point of release to health effects after inhalation, with the overall goal of informing policy change.
Narghile waterpipe tobacco smoke: toxicant dose, delivery, and effects
Does waterpipe smoke contain significant toxicants? To what extent are these absorbed by the user? Is waterpipe smoke biologically active? Does inhaling it lead to immediate measureable health consequences? Does smoking a waterpipe lead to addiction? Is second-hand waterpipe smoke hazardous? Should waterpipe smoking be exempted from public smoking bans?
Over the past decade, investigators at the Aerosol Lab have been working to elucidate the potential health consequences of smoking the narghile waterpipe (aka shisha, hookah), a centuries-old but little-studied tobacco use method prevalent in Southwest Asia and North Africa, and increasingly around the world. Through analytical, biological, and clinical investigations with our collaborators, we are learning what toxicants first-hand and second-hand waterpipe smokers inhale, the degree to which some of these toxicants are absorbed in the body (i.e. appear in blood and urine), and resulting acute physiological (e.g. heart rate variability, lung function) and subjective effects (e.g. desire to smoke). We are also studying the ability of waterpipe smoke to disrupt lifecycles and induce inflammatory responses in human cells, as well as effects of smoke exposure on animals. This multi-pronged approach is driven by a central goal of gathering converging lines of evidence that are needed to inform tobacco control policy. It will also inform design of long-term epidemiological studies of health outcomes, and make known to consumers potential hazards of waterpipe smoking.
In the course of conducting these investigations, we have developed several unique instruments including those used to measure waterpipe puff topography (the way people puff) and to automatically sample smoke from waterpipes when used in cafés and homes. We also developed a smoking robot that replicates human puffing behavior in detail resolved to 100 ms for chemical and biological assays in the laboratory, and an artificial-lung waterpipe smoking machine to study second-hand smoke from the waterpipe and its user. Some of these instruments are also being used by our collaborators at the Clinical Behavioral Pharmacology Lab at Virginia Commonwealth University, the Syrian Center for Tobacco Studies, Jordan University of Science and Technology, and other investigators in Europe and North America. We also developed the Beirut Method, a protocol for waterpipe smoking machine testing of waterpipe tobacco products which was validated against inhaled toxicant doses measured in waterpipe users in cafés.
Our work has been critical for informing public health and regulatory responses to the growing worldwide epidemic of waterpipe tobacco smoking, and is widely cited in the literature. The Aerosol Lab regularly advises international and local agencies on the health effects and applicability of tobacco control regulations to waterpipe tobacco smoking.
Current funding: US National Cancer Institute, R01 CA120142, R01 DA025659
Volatility and evaporation kinetics of atmospheric aerosols
|It has been widely recognized that regional air pollution models generally under-predict formation of aerosol particles in the atmosphere by a large margin, thereby hampering efforts to evaluate policy options aimed at improving air quality. One reason for this discrepancy is thought to be the poor state of knowledge regarding semi-volatile species that are important in atmospheric particle formation, a gap stemming from challenges of accurately measuring the vapor pressure and the molecular accommodation/evaporation coefficient of complex, time-varying, low vapor pressure materials. |
In partnership with the Khlystov Aerosol Research Lab at Duke University we have developed from first principles thermodenuder-based methods (IV-TDMA and Equilibration Profile) to measure these properties in the lab. Our key methodological contribution to this field has been to experimentally decouple overlapping thermodynamic and kinetic constraints on particle evaporation. By doing so, we have been able to report first determinations of evaporation coefficient for a number of organic compounds and mixtures relevant to atmospheric air pollution, and have revised previously reported values of their vapor pressures. We have also reported first determinations of the effective evaporation coefficient of concentrated atmospheric particles sampled in Beirut in the summer of 2010. The data showed that these are of the order 10-1, indicating that ambient aerosol may be significantly more volatile than previously estimated from field measurements made under the assumption that the coefficient is unity. This difference would, at least in part, account for “missing aerosol” in ambient pollution models.
Using computational and experimental means we have also studied the problem of growth and evaporation of hygroscopic aerosol particles in bounded flows with wall heat and mass transfer, a problem fundamental to predicting the fraction and location inhaled particles deposit in the human respiratory system. This is relevant to understanding health effects of inhaled pollutants and to designing respiratory drug delivery devices.
Rima Afifi, Monique Chaaya, Rima Nakkash, Faculty of Health Sciences, AUB
Greg Connolly, Center for Global Tobacco Control, Harvard University
Thomas Eissenberg, Clinical Behavioral Pharmacology Lab, Virginia Commonwealth University
Omar Khabbour, Karem Al-Zoubi, Medical Laboratory Sciences, Jordan University of Science & Technology
Andrey Khlystov, Khlystov Aerosol Research Lab, Duke University
Lennart Larson, Medical Microbiology, Lund University
Gabriel Katul, School of the Environment, Duke University
Wasim Maziak, Syrian Center for Tobacco Studies, Aleppo
Marwan Sabban, Department of Anatomy, Cell Biology, and Physiology, AUB
Najat Saliba, Atmospheric & Analytical Lab, Department of Chemistry AUB
Constantinos Sioutas , University of Southern California Aerosol Research Lab
Ghazi Zaatari, Pathology & Laboratory Medicine, AUB
Constantinos Sioutas, University of Southern California Aerosol Research Lab